Outset Medical (OM) Amortization of Deferred Charges (2019 - 2026)
Outset Medical's (OM) quarterly Amortization of Deferred Charges came in at $700000.0 in Q1 2026, up 10.06% year-on-year from $636000.0 in Q1 2025, and down 1.82% on a QoQ basis from $713000.0 in Q4 2025.
Outset Medical (OM) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
Outset Medical (OM) has 8 years of Amortization of Deferred Charges data on file, last reported at $700000.0 in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 10.06% year-over-year to $700000.0 in Q1 2026; TTM through Mar 2026 was $2.8 million, a 8.41% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, up 7.15% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $700000.0, down from $713000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for OM reached as high as $713000.0 in Q4 2025 and fell as low as -$45000.0 in Q4 2022.
- Historically, Amortization of Deferred Charges has averaged $484764.7 across 5 years, with a median of $607000.0 in 2024.
- Across the five-year window, Amortization of Deferred Charges slumped 131.47% in 2022 and jumped 1102.22% in 2023, its largest moves.
- Year by year, Amortization of Deferred Charges stood at -$45000.0 in 2022, then soared by 1102.22% to $451000.0 in 2023, then jumped by 49.89% to $676000.0 in 2024, then advanced by 5.47% to $713000.0 in 2025, then retreated by 1.82% to $700000.0 in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $700000.0 in Q1 2026, $713000.0 in Q4 2025, and $710000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | Outset Medical | 78,544.58 | -286.57 Mn | 12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 700,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Sep 30, 2025 | 710,000.00 |
| Sep 30, 2025 | 710,000.00 |
| Jun 30, 2025 | 699,000.00 |
| Jun 30, 2025 | 699,000.00 |
| Mar 31, 2025 | 636,000.00 |
| Mar 31, 2025 | 636,000.00 |
| Dec 31, 2024 | 676,000.00 |
| Dec 31, 2024 | 676,000.00 |
| Sep 30, 2024 | 657,000.00 |
| Sep 30, 2024 | 657,000.00 |
| Jun 30, 2024 | 634,000.00 |
| Jun 30, 2024 | 634,000.00 |
| Mar 31, 2024 | 607,000.00 |
| Mar 31, 2024 | 607,000.00 |
| Dec 31, 2023 | 451,000.00 |
| Dec 31, 2023 | 451,000.00 |